Diabetes

People with diabetes may be prone to more skin infections due to an overabundance of a compound that controls inflammation in the body. Read More

The Vanderbilt Diabetes Center, the Vanderbilt Diabetes Research and Training Center (DRTC), and the Vanderbilt Center for Diabetes Translation Research (CDTR) announce the availability of pilot and feasibility grants in the following areas. Read More

New research by an international team that includes Vanderbilt researchers shows how a common diabetes drug blocks glucose production by the liver, suggesting new avenues for treatment. Read More

Health Plus is offering new sessions of the one-year lifestyle change program, the National Diabetes Prevention Program, for faculty/staff or spouses with prediabetes or a history of gestational diabetes. Read More

A drug used to treat diabetes, liraglutide, may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. Read More

Summer outings and getaways should be fun and relaxing for everyone. And they can be — even if you’ve got meds and supplies to pack for your child with diabetes. Read More

Non-exercise physical activity has a measurable energy expenditure, which goes down when animals engage in voluntary exercise, Vanderbilt researchers have discovered. Read More

Vanderbilt investigators and colleagues around the country have made a major discovery that could lead to better ways to treat type 1 diabetes (T1D). Read More

Rising obesity rates in several Southern states are leading to a rapid increase in new cases of diabetes among both black and white adults. A new study helmed by investigators at the University of Texas Health Science Center and Vanderbilt University Medical Center (VUMC) found the risk of diabetes is double for black patients. Read More

Potassium channels in a cellular organelle regulate calcium flux and appear to play a critical role in pancreatic beta cell health. Read More

One of our favorite prediabetes success stories includes lifestyle overhaul and the help of a program focused on manageable change: Health Plus at Vanderbilt. Read More

Investigators in the Vanderbilt Diabetes Research and Training Center (VDRTC) and collaborators at Stanford University have discovered new insights into the molecular mechanisms of cell proliferation in juvenile human pancreatic islets, information that could lead to new treatments for diabetes. Read More

Health Plus is offering new sessions of the National Diabetes Prevention Program​ for faculty or spouses. Qualifications for enrollment include having pre-diabetes, being at risk for developing type 2 diabetes, or have a history of gestational diabetes. Read More

Health Plus is offering new sessions of the national Diabetes Prevention Program​ for faculty, staff and/or their spouses with prediabetes or a history of gestational diabetes. Read More

Eighteen-year-old Grace Long had just been accepted at the renowned United States Naval Academy, with plans to become a nuclear engineering officer. Then, she learned she had type 1 diabetes, an immediate disqualifier for military service. Read More

In Middle Tennessee, where roughly one-third of children are overweight or obese, the risk of developing pediatric type 2 diabetes is high and the consequences can be serious. Read More

High circulating glucose, the hallmark of diabetes, is linked to the disease’s most serious complications including heart disease, kidney failure, blindness and amputation. Diabetes is the sixth leading cause of death and costs the nation an estimated $322 billion a year. Restoring the action of insulin has been the traditional… Read More

Shichun Bao, M.D., Ph.D., associate professor of Medicine, unclips an insulin pump smaller than a deck of cards from her waistband to glance at its digital readout — but she doesn’t actually have diabetes and the pump contains only saline. Read More

Interventions that increase circulating levels of compounds called EETs may improve insulin sensitivity and treat hypertension. Read More

Vanderbilt investigators have identified novel regulators of insulin-producing beta-cell proliferation and survival, suggesting new targets for the treatment of type 2 diabetes. Read More